Y Mizutani Selected Research

Y Mizutani Research Topics

Disease

8	Neoplasms (Cancer) 11/2005 - 01/2001
5	Renal Cell Carcinoma (Grawitz Tumor) 03/2003 - 06/2000
3	Carcinoma (Carcinomatosis) 01/2003 - 07/2001
3	Urinary Bladder Neoplasms (Bladder Cancer) 08/2001 - 01/2001
2	Wounds and Injuries (Trauma) 09/2008 - 07/2008
2	Erectile Dysfunction 07/2005 - 08/2002
2	Necrosis 03/2002 - 01/2002
1	Alveolar Bone Loss 08/2014
1	Radicular Cyst 08/2014
1	Periodontitis 08/2014
1	Osteoporosis 08/2014
1	Leukemia 06/2014
1	Spotted Fever Group Rickettsiosis (Rickettsialpox) 03/2012
1	Vasculitis (Vasculitides) 03/2009
1	Oculomotor Nerve Diseases (Oculomotor Nerve Palsy) 03/2009
1	Prolapse 07/2008
1	Restless Legs Syndrome (Restless Legs) 12/2006
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 03/2003
1	Prostatic Neoplasms (Prostate Cancer) 03/2003
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2003
1	Esophageal Squamous Cell Carcinoma 01/2003
1	Deglutition Disorders (Dysphagia) 01/2003
1	Pathologic Constriction (Stenosis) 01/2003
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2002
1	Diabetes Complications 08/2002
1	Renal Insufficiency (Renal Failure) 06/2002
1	Embryonal Carcinoma 03/2002
1	Neoplasm Metastasis (Metastasis) 03/2002
1	Teratoma (Teratoid Tumor) 03/2002
1	Ascites 10/2001
1	Hepatocellular Carcinoma (Hepatoma) 10/2001
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2001
1	Breast Neoplasms (Breast Cancer) 02/2001
1	Brain Neoplasms (Brain Tumor) 02/2001
1	Hyperglycemia 01/2001
1	Body Weight (Weight, Body) 06/2000
1	Birth Weight (Birth Weights) 06/2000
1	Testicular Neoplasms (Testicular Cancer) 04/2000
1	Oculopharyngeal Muscular Dystrophy 03/2000

Drug/Important Bio-Agent (IBA)

5	EnzymesIBA 08/2014 - 03/2001
5	Fluorouracil (Carac)FDA LinkGeneric 03/2003 - 03/2001
4	Cisplatin (Platino)FDA LinkGeneric 03/2003 - 01/2001
4	Antineoplastic Agents (Antineoplastics)IBA 08/2001 - 04/2000
3	LigandsIBA 06/2014 - 01/2001
3	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 03/2003 - 03/2001
3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2001 - 06/2000
2	Fas Ligand Protein (Fas Ligand)IBA 03/2003 - 07/2001
2	Carboplatin (JM8)FDA LinkGeneric 03/2001 - 01/2001
1	Proteins (Proteins, Gene)FDA Link 08/2014
1	AntibodiesIBA 08/2014
1	AntigensIBA 08/2014
1	Tissue ExtractsIBA 08/2014
1	Butoxamine (Butaxamine)IBA 08/2014
1	ParaffinIBA 03/2012
1	Formaldehyde (Formol)FDA Link 03/2012
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/2009
1	Biomarkers (Surrogate Marker)IBA 11/2005
1	Tumor Biomarkers (Tumor Markers)IBA 11/2005
1	Sildenafil Citrate (Viagra)FDA Link 07/2005
1	ResveratrolIBA 03/2003
1	Therapeutic UsesIBA 03/2003
1	Pharmaceutical PreparationsIBA 03/2003
1	LipidsIBA 03/2003
1	PolymersIBA 03/2003
1	Dendrimers (Dendrons)IBA 03/2003
1	Poly(amidoamine)IBA 03/2003
1	Aldehyde Reductase (Aldose Reductase)IBA 08/2002
1	Caspase 8 (Caspase-8)IBA 03/2002
1	Complementary DNA (cDNA)IBA 03/2002
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 10/2001
1	FluorodeoxyuridylateIBA 08/2001
1	Thymidylate SynthaseIBA 08/2001
1	ChromiumIBA 07/2001
1	ImmunosorbentsIBA 07/2001
1	IsotopesIBA 07/2001
1	Vinblastine (Vinblastine Sulfate)FDA Link 07/2001
1	Caspase 3 (Caspase-3)IBA 07/2001
1	AnthracyclinesIBA 07/2001
1	anti-Fas monoclonal antibodyIBA 05/2001
1	Radiation-Sensitizing AgentsIBA 03/2001
1	nedaplatinIBA 03/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2001
1	Streptozocin (Streptozotocin)FDA Link 01/2001
1	Blood Glucose (Blood Sugar)IBA 06/2000
1	Etoposide (VP 16)FDA LinkGeneric 04/2000
1	Poly(A)-Binding Protein IIIBA 03/2000

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 11/2005 - 04/2000
3	Renal Dialysis (Hemodialysis) 12/2006 - 06/2002
2	Cannula 09/2008 - 07/2008
2	Therapeutics 11/2005 - 04/2000
2	Chemoradiotherapy 01/2003 - 03/2001
2	Radiotherapy 03/2001 - 02/2001
1	Tooth Movement Techniques 08/2014
1	Vitrectomy 07/2008
1	Immunotherapy 11/2005
1	Chemoprevention 03/2003
1	Injections 03/2003